Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
644 |
|
| Actual shortage: | 11 (2%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RILUZOLE | 50MG | TABLET | Avoided shortage | 2021-01-20 | 2021-02-09 | 132026 |
| MYLAN-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-20 | 2021-02-24 | 132033 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-02-05 | 2021-03-17 | 133432 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-09 | 2022-08-25 | 133595 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-03-17 | 2021-04-19 | 135792 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-03-17 | 2021-05-19 | 135797 |
| MYLAN-RILUZOLE | 50MG | TABLET | Resolved | 2021-03-24 | 2021-04-07 | 136159 |
| MYLAN-RILUZOLE | 50MG | TABLET | Avoided shortage | 2021-04-07 | 2021-04-28 | 136961 |
| CLARUS | 10MG | CAPSULE | Resolved | 2021-04-13 | 2021-06-24 | 137415 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-20 | 2021-05-27 | 137769 |
| VITAMIN C | 500MG | SOLUTION | Resolved | 2021-06-01 | 2021-06-08 | 140155 |
| MYLAN-CINACALCET | 60MG | TABLET | Avoided shortage | 2021-06-08 | 2021-07-21 | 140541 |
| CLARUS | 40MG | CAPSULE | Avoided shortage | 2021-06-30 | 2021-10-13 | 141672 |
| CLARUS | 10MG | CAPSULE | Resolved | 2021-06-30 | 2021-12-21 | 141675 |
| MYLAN-RILUZOLE | 50MG | TABLET | Avoided shortage | 2021-08-18 | 2021-09-09 | 144291 |
| MYLAN-VARDENAFIL | 10MG | TABLET | Resolved | 2021-09-09 | 2021-10-26 | 145397 |
| MYLAN-RILUZOLE | 50MG | TABLET | Resolved | 2021-10-13 | 2021-10-26 | 146987 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Avoided shortage | 2021-10-13 | 2021-10-26 | 146990 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Resolved | 2021-10-26 | 2021-11-17 | 148028 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2021-11-17 | 2021-12-21 | 149495 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |